Syndicate This week's upcoming IPO's and secondary offerings

Week of January 30 to February 3, 2024

This Week's Deals to be Priced

02/01 - Wednesday

Symbol

Issuer

Type

Price

Managers

BBRX

Braeburn Pharmaceuticals
Braeburn Pharmaceuticals
IPO
Postponed $18.00-21.00
7.692M
JPMorgan & BofA,...

Pricing after close
Deal analysis and details

Managers: JPMorgan & BofA, Deutsche Bank, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/02 - Thursday

Symbol

Issuer

Type

Price

Managers

ICP

IC Power
IC Power
IPO
Postponed $12.00-15.00
25.9M
BofA & Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: BofA & Credit Suisse, Goldman Sachs, UBS, HSBC, Scotiabank, Credicorp

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

01/30 - Monday

Symbol

Issuer

Type

Price

Managers

NRZ

New Residential
New Residential
Secondary
Priced: $15.00
49.17M
Citi,...

Pricing after close

Managers: Citi, Barclays, BofA & Credit Suisse, BTIG, FBRC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RIGL

Rigel Pharmaceuticals
Rigel Pharmaceuticals
Spot Secondary
Priced: $2.00
20M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Piper Sandler & BMO Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SMLP

Summit Midstream
Summit Midstream
Spot Secondary
Priced: $24.00
4M
Barclays

Pricing after close
Deal analysis and details

Managers: Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

01/31 - Tuesday

Symbol

Issuer

Type

Price

Managers

INVH

Invitation Homes
Invitation Homes
IPO
Priced: $20.00
77M
Deutsche Bank,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Deutsche Bank, JPMorgan, BofA, Goldman Sachs & Wells Fargo, Credit Suisse, Morgan Stanley, RBC Capital, Blackstone, BTIG, Evercore ISI, FBRC, JMP Securities, Keefe Bruyette, Raymond James, Siebert, Zelman

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LAUR

Laureate Education
Laureate Education
IPO
Priced: $14.00
35M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Morgan Stanley, Barclays, Macquarie, JPMorgan, BMO Capital, Citi & Goldman Sachs, Baird, Barrington, Piper Sandler, Stifel, William Blair, Bradesco, BTG Pactual

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FHB

First Hawaiian
First Hawaiian
Secondary
Priced: $32.00
25M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, BofA, JPMorgan & BNP Paribas, Barclays, Citi, Credit Suisse, Deutsche Bank

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MCRN

Milacron
Milacron
Secondary
Priced: $16.25
12M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Barclays & JPMorgan, BAIRD, Credit Suisse & Goldman Sachs, KeyBanc, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TMHC

Taylor Morrison
Taylor Morrison
Secondary
Priced: $19.00
10M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi & Credit Suisse, Deutsche Bank, BofA, Goldman Sachs, Wells Fargo, Zelman, HSBC, TPG Capital, Comerica

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SGYP

Synergy Pharmaceuticals
Synergy Pharmaceuticals
Spot Secondary
Priced: $6.15
20.3M
Cantor Fitzgerald & Canaccord

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald & Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SN

Sanchez Energy
Sanchez Energy
Spot Secondary
Priced: $12.50
10M
JPMorgan

Pricing after close
Deal analysis and details

Managers: JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
UNVR

Univar
Univar
Spot Secondary
Priced: $29.00
15M
Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/01 - Wednesday

Symbol

Issuer

Type

Price

Managers

NTB

Butterfield
Butterfield
Block Trade
Priced: $32.75
375K
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CBAY

CymaBay Therapeutics
CymaBay Therapeutics
Secondary
Priced: $1.93
5.181M
JonesTrading Institutional Services,...

Pricing after close

Managers: JonesTrading Institutional Services, LifeSci Capital LLC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SND

Smart Sand
Smart Sand
Secondary
Priced: $17.50
5.95M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Goldman Sachs & Jefferies, Piper Sandler, TPH&Co., Deutsche Bank

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CORI

Corium
Corium
Spot Secondary
Priced: $3.00
6.667M
Cantor Fitzgerald

Pricing after close

Managers: Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CVEO

Civeo
Civeo
Spot Secondary
Priced: $3.00
20M
RBC Capital

Pricing after close
Deal analysis and details

Managers: RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FBP

First BanCorp
First BanCorp
Spot Secondary
Priced: $6.43
20M
Citi & UBS

Pricing after close
Deal analysis and details

Managers: Citi & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/02 - Thursday

Symbol

Issuer

Type

Price

Managers

RUBI

Rubicon Project
Rubicon Project
Block Trade
Priced: $7.70
3.9M
Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KRP

Kimbell Royalty Partners
Kimbell Royalty Partners
IPO
Priced: $18.00
5M
Raymond James,...

Pricing after close
Deal analysis and details

Managers: Raymond James, RBC Capital & Stifel, Stephens, WUND

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
METC

Ramaco Resources
Ramaco Resources
IPO
Priced: $13.50
6M
Credit Suisse,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Credit Suisse, Jefferies & BMO Capital, Clarksons Platou, GHSC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IDXG

Interpace Diagnostics
Interpace Diagnostics
Secondary
Priced: $3.00
1.2M
Maxim,...

Pricing after close

Managers: Maxim, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NEOS

Neos Therapeutics
Neos Therapeutics
Spot Secondary
Priced: $5.00
5M
TD Cowen & BMO Capital

Pricing after close
Deal analysis and details

Managers: TD Cowen & BMO Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access